$50.67
-1.48 (-2.84%)
At Close: Jun 18, 2026
Chemotheraphy-induced Nausea and Vomitting Treatment Market Global Briefing and Research 2021 | GlaxoSmithKline, Helsinn, Heron Therapeutics
12:19pm, Monday, 06'th Dec 2021 OpenPR
The Global Chemotheraphy-induced Nausea and Vomitting Treatment Market report offers a comprehensive evaluation of the market. It does give in-depth analysis via qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been
Narcotic Analgesics Market with Attractiveness, Competitive Landscape & Forecasts to 2027| Sanofi S.A., Novartis AG, GlaxoSmithKline PLC
12:17pm, Monday, 06'th Dec 2021 OpenPR
The global Narcotic Analgesics market size is projected a CAGR of 4.6% during 2021-2027. The ageing population''s frequent pain and aches, rising incidences of cardiovascular disease (CVD), cancer, and arthritis, and rising public and private sector R&D spending, with a
Healthcare Information Technology Services Market Huge Growth in Future Scope 2021-2028 | GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Ltd.
09:28am, Monday, 06'th Dec 2021 OpenPR
Another factual information on the "Global Healthcare Information Technology Services Market" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces
HPV Therapeutic Vaccines Market Analysis, Status and Business Outlook 2021 to 2029 |Merck & Co., Inc, GlaxoSmithKline plc
04:09am, Monday, 06'th Dec 2021 OpenPR
Global HPV Therapeutic Vaccines Sales Market Report 2021 The HPV Therapeutic Vaccines Market Report 2021-2027 provides global market size, regional and national level market size, market segment growth, market share, competitive landscape, sales analysis, influence of domestic and global market participants,
GlaxoSmithKline plc (NYSE:GSK) Short Interest Down 20.9% in November
11:38am, Sunday, 05'th Dec 2021 Transcript Daily
GlaxoSmithKline plc (NYSE:GSK) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 12,330,000 shares, a drop of 20.9% from the October 31st total of 15,580,000 shares. Based on an average daily volume of 4,130,000 shares, the short-interest ratio is currently 3.0 days. Approximately []
Ledyard National Bank Has $369,000 Stake in GlaxoSmithKline plc (NYSE:GSK)
03:56pm, Saturday, 04'th Dec 2021 Dakota Financial News
Ledyard National Bank boosted its holdings in shares of GlaxoSmithKline plc (NYSE:GSK) by 3.2% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 9,651 shares of the pharmaceutical companys stock after buying an additional 300 shares during the period. Ledyard National Banks holdings in GlaxoSmithKline were worth $369,000 as of its most recent SEC []
Narrative Pharmaceuticals: Omicron vs. GlaxoSmithKline and Vir''s Treatment
09:51pm, Friday, 03'rd Dec 2021 GuruFocus
Preclinical data demonstrates sotrovimab retains activity against key Omicron mutations Related Stocks: GSK , LSE:GSK , AZN , LLY , REGN , VIR , SNY ,
Neurology Clinical Trials Market Forecast With Reports On Novartis, Medpace, Syneous Health, GlaxoSmithKline
06:49pm, Friday, 03'rd Dec 2021 OpenPR
A clinical trial is a research investigation in which individuals can participate. The intent of a clinical trial is to investigate the efficacy of a treatment, medication, experimental drug or instrument. Clinical trials in the field of neurology constitute neurology
Anti-Obesity Therapeutics Market Primary and Secondary Research|Bristol-Myers Squibb, Eisai Company, GlaxoSmithKline plc, Novo Nordisk
06:38pm, Friday, 03'rd Dec 2021 OpenPR
Anti-obesity therapies are drugs that help people lose or maintain their weight. These drugs affect one of the body''s most basic functions, weight control, by affecting appetite or calorie absorption. Diet and physical activity remain the main therapeutic strategies for
Topical Drug Delivery Market Recovery and Impact Analysis Report |Johnson & Johnson, GlaxoSmithKline, Novartis, Nestle
03:53pm, Friday, 03'rd Dec 2021 OpenPR
Increasing prevalence of skin infections such as eczema and psoriasis, as well as minor diseases such as acne, is one of the factors responsible for the growth of the topical drug delivery market. Preference for drug delivery through the skin
A Comprehensive Study Exploring DNA Vaccines Market | Key Players Bharat Biotech, Glaxosmithkline, Green Cross, Dendreon
12:19pm, Friday, 03'rd Dec 2021 OpenPR
The Latest survey report on Global DNA Vaccines Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, DNA Vaccines organizations have the dual challenge of increasing interoperability to improve clinical
Omicron Cure: GlaxoSmithKline says early data shows its Covid antibody drug effective against new variant
10:23am, Friday, 03'rd Dec 2021 IBTimes India
British drugmaker GlaxoSmithKline has claimed that early laboratory tests show that its antibody drug against Covid-19 is effective against the new super mutant Omicron variant.
GSKs early data shows Covid antibody drug effective against Omicron
09:05am, Friday, 03'rd Dec 2021 Buziness Bytes
London, Dec 3 (IANS) British drugmaker GlaxoSmithKline has claimed that early laboratory tests show that its antibody drug against Covid-19 is effective against the new super mutant Omicron variant. GSK developed Sotrovimab, with US partner Vir Biotechnology, a monoclonal antibody based on the natural antibodies humans already make. In clinical trials, sotrovimab was shown to [] The post GSKs early data shows Covid antibody drug effective against Omicron appeared first on Buziness Bytes .
UK approves GlaxoSmithKline Covid drug, appears effective against Omicron
07:00am, Friday, 03'rd Dec 2021 The New Indian Express
Preclinical data showed that sotrovimab "retains activity against key mutations of the new Omicron SARS-CoV-2 variant," GlaxoSmithKline said in a statement.
Pfizer Jab & GSK''s Antibody Drug Are Effective Against Omicron
05:00pm, Thursday, 02'nd Dec 2021 Zero Hedge
Pfizer Jab & GSK''s Antibody Drug Are Effective Against Omicron After teasing various aspects of his plan to protect Americans from the omciron variant (which is arriving at the start of the latest ''winter wave'') while the CDC quietly collects names of travelers who recently visited southern Africa, President Joe Biden is preparing to share his plan, which will impose tighter restrictions on foreign travelers while extending a mask mandate and (potentially) double down on vaccine restrictions for American workers (even as multiple federal judges have rejected the mandate). Biden''s comments are expected later on Thursday, but during the early hours of the US session, Germany''s outgoing Chancellor Angela Merkel and her successor, Olaf Scholz, agreed on a plan to effectively mandate vaccinations by imposing stringent restrictions on Germans who haven''t voluntarily gotten the jab. As governments scramble to use omicron as an excuse to crack down on the unvaccinated, makers of vaccines and COVID remedies have continued to share data about their products'' efficacy at combating the omicron variant.
Sign In
Buy GSK